Patent · US Active

Derivatives of piperlongumine and uses thereof

US11485725B2 · kind B2 · utility

0Cited by
6References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 14, 2018
Grant dateNov 1, 2022
Priority date
Expiry dateNov 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/056
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a group of 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one (piperlongumine) derivatives, analogs and pharmaceutically acceptable salts thereof. The present invention also relates to processes for preparing the same; a pharmaceutical composition and formulation containing a derivative of piperlongumine; and use of the derivatives and analogs for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.